It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Fibro-adipogenic progenitors (FAPs) are currently defined by their anatomical position, expression of non-specific membrane-associated proteins, and ability to adopt multiple lineages in vitro. Gene expression analysis at single-cell level reveals that FAPs undergo dynamic transitions through a spectrum of cell states that can be identified by differential expression levels of Tie2 and Vcam1. Different patterns of Vcam1-negative Tie2high or Tie2low and Tie2low/Vcam1-expressing FAPs are detected during neonatal myogenesis, response to acute injury and Duchenne Muscular Dystrophy (DMD). RNA sequencing analysis identified cell state-specific transcriptional profiles that predict functional interactions with satellite and inflammatory cells. In particular, Vcam1-expressing FAPs, which exhibit a pro-fibrotic expression profile, are transiently activated by acute injury in concomitance with the inflammatory response. Aberrant persistence of Vcam1-expressing FAPs is detected in DMD muscles or upon macrophage depletion, and is associated with muscle fibrosis, thereby revealing how disruption of inflammation-regulated FAPs dynamics leads to a pathogenic outcome.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Development, Aging and Regeneration Program at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA; Avidity Biosciences LLC, La Jolla, CA, USA
2 Development, Aging and Regeneration Program at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA; Monoceros Biosystems LLC, San Diego, CA, USA
3 Development, Aging and Regeneration Program at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
4 IRCCS Fondazione Santa Lucia, Rome, Italy; Department of Biology, University of Rome Tor Vergata, Rome, Italy
5 Flow Cytometry Core, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA
6 Development, Aging and Regeneration Program at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
7 Development, Aging and Regeneration Program at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA; Sorbonne Université, INSERM UMRS974, Association Institut de Myologie, Centre de Recherche en Myologie, Paris, France
8 Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, Rome, Italy; Institute of Cell Biology and Neurobiology (IBCN), National Research Council of Italy (CNR), Rome, Italy
9 IRCCS Fondazione Santa Lucia, Rome, Italy
10 Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
11 Development, Aging and Regeneration Program at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA; IRCCS Fondazione Santa Lucia, Rome, Italy